Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-07-18Clinical Trial Update: Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies [Phase 1]
Phase 1 trial evaluating intravenous palifosfamide-tris in combination with etoposide and carboplatin in patients with various malignancies;…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) [Phase 2]
This Phase II trial in previously untreated non-small cell lung cancer and small cell lung cancer has completed, with results posted in 2012…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating how UGT1A1 gene polymorphisms influence the toxicity and efficacy of irinotecan in patients with small …
-
CLINICAL_TRIALS research · 2012-07-03Clinical Trial Update: Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update evaluating maintenance therapy with autologous cytokine-induced killer cells for small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial of autologous stem cell transplantation followed by a dendritic cell vaccine targeting p53 in patients with limited-stage smal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 safety trial evaluating weekly infusions of BB-10901 in patients with Small Cell Lung Cancer has been completed and results were…
-
CLINICAL_TRIALS research · 2012-06-13Clinical Trial Update: S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer [Phase 2]
This clinical trial update notes that the Phase 2 SWOG trial combining chemotherapy, radiation therapy, and vaccine therapy for limited-stag…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) [Phase 2]
A Phase 2 adjuvant trial of bemiparin for small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial comparing carboplatin and etoposide with or without thalidomide in small cell lung cancer has completed.
-
FDA approval · 2012-03-15FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulat…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating a vaccination therapy for limited-stage small cell lung cancer has completed. The update summarizes trial status an…
-
CLINICAL_TRIALS withdrawal · 2012-02-09Clinical Trial Update: INNO-206 in Patients With Small Cell Lung Cancer (SCLC) [Phase 2]
CytRx has withdrawn its Phase 2 clinical trial of INNO-206 for small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of OSI-211 (liposomal lurtotecan) for recurrent small cell lung cancer; the study has completed and reports on efficacy…
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer [Phase 2]
Phase 2 trial of chloroquinoxaline sulfonamide for small cell lung cancer has completed.
-
FDA approval · 2011-10-07FDA Approved: HYCAMTIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for HYCAMTIN (topotecan) submitted by Sandoz Inc.
-
CLINICAL_TRIALS research · 2011-09-07Clinical Trial Update: A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients [Phase 2]
This is a Phase 2 prospective study evaluating variation in breath-holding times during radiotherapy in lung cancer patients and the impact …
-
FDA approval · 2011-08-26FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC, resulting in an updated regulatory status for the …
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer [Phase 2]
This document outlines a Phase 2 trial evaluating pasireotide LAR in combination with topotecan for relapsed or refractory small cell lung c…
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for PR104 in patients with previously untreated or relapsed small cell lung cancer; the study (NCT00544674) co…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating epoetin alfa for the treatment of anemia in cancer patients receiving chemotherapy; study completed.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer [Phase 2]
This document provides an update on a Phase 2 trial evaluating paclitaxel plus bevacizumab in chemosensitive relapsed small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer [Phase 2]
This update indicates the termination of a Phase 2 study of pemetrexed in patients with chemosensitive and chemoresistant relapsed small cel…
-
CLINICAL_TRIALS research · 2011-03-03Clinical Trial Update: Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors [Phase 2]
Phase 2 trial investigating hyperthermia/thermal therapy with chemotherapy for inoperable or metastatic tumors. The listed conditions includ…
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating oral topotecan in combination with bevacizumab for recurrent small cell lung cancer has completed and re…
-
FDA approval · 2010-12-02FDA Approved: TOPOTECAN HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approved the original application for Topotecan Hydrochloride from Actavis Pharma, Inc. as a generic cancer therapy.